PFE
Pfizer Inc.
- Total liabilities, 2025
- $121.4B
- YoY, 2025
- −2.8%
- 5-year CAGR
- +6.0%
- 10-year CAGR
- +1.7%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $121.4B | −2.8% |
| 2024 | $124.9B | −9.0% |
| 2023 | $137.2B | +35.5% |
| 2022 | $101.3B | −2.6% |
| 2021 | $104.0B | +14.6% |
| 2020 | $90.8B | −12.9% |
| 2019 | $104.1B | +8.9% |
| 2018 | $95.7B | −4.5% |
| 2017 | $100.1B | −10.4% |
| 2016 | $111.8B | +9.2% |
| 2015 | $102.4B | +6.7% |
| 2014 | $95.9B | +0.5% |
| 2013 | $95.5B | −8.3% |
| 2012 | $104.1B | −1.2% |
| 2011 | $105.4B | −1.3% |
| 2010 | $106.7B | −12.9% |
| 2009 | $122.5B | +129.4% |
| 2008 | $53.4B | — |